Adenosine A(3) receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity. - Wikidata - wikimedia - TriplyDB

Adenosine A(3) receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity.

Adenosine A(3) receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity.

http://www.wikidata.org/entity/Q37399268

about

Purinergic signalling and cancer Dinosaurs and ancient civilizations: reflections on the treatment of cancer The anti-tumor effect of A3 adenosine receptors is potentiated by pulsed electromagnetic fields in cultured neural cancer cells NOX3 NADPH oxidase couples transient receptor potential vanilloid 1 to signal transducer and activator of transcription 1-mediated inflammation and hearing loss Short interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammation Adenosine arrests breast cancer cell motility by A3 receptor stimulation.Molecular mechanisms of A3 adenosine receptor-induced G1 cell cycle arrest and apoptosis in androgen-dependent and independent prostate cancer cell lines: involvement of intrinsic pathway.NOX4 promotes non-small cell lung cancer cell proliferation and metastasis through positive feedback regulation of PI3K/Akt signaling.Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt/MicroRNA-21 pathway NADPH oxidase pathway is involved in aortic contraction induced by A3 adenosine receptor in mice.The interconnectedness of cancer cell signaling.Pharmacological and therapeutic effects of A3 adenosine receptor agonists A3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways.Molecular expression of adenosine receptors in OVCAR-3, Caov-4 and SKOV-3 human ovarian cancer cell lines CF102 an A3 adenosine receptor agonist mediates anti-tumor and anti-inflammatory effects in the liver.Characterization by flow cytometry of fluorescent, selective agonist probes of the A(3) adenosine receptor.Investigational A₃ adenosine receptor targeting agents.Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea.Modulation of G protein-coupled adenosine receptors by strategically functionalized agonists and antagonists immobilized on gold nanoparticles.Identification of A3 adenosine receptor agonists as novel non-narcotic analgesics.ROS signaling by NADPH oxidase 5 modulates the proliferation and survival of prostate carcinoma cells.The War on Cancer rages on.Adenosine receptors: expression, function and regulation.Adenosine receptor targeting in health and disease.Purinergic signalling in the lower urinary tract.Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity.Apoptosis and cell cycle regulatory effects of adenosine by modulation of GLI-1 and ERK1/2 pathways in CD44+ and CD24- breast cancer stem cells.Extracellular purines, purinergic receptors and tumor growth.Activation of A2b adenosine receptor regulates ovarian cancer cell growth: involvement of Bax/Bcl-2 and caspase-3.Expression of adenosine receptor subclasses in malignant and adjacent normal human prostate tissues.Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer.A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy.Purinergic Signalling: Therapeutic Developments.Essential role of NADPH oxidase-dependent reactive oxygen species generation in regulating microRNA-21 expression and function in prostate cancer.Multifaceted Effects of Extracellular Adenosine Triphosphate and Adenosine in the Tumor-Host Interaction and Therapeutic Perspectives.A3 Adenosine Receptor Agonist Inhibited Survival of Breast Cancer Stem Cells via GLI-1 and ERK1/2 Pathway.Beyond androgen deprivation: ancillary integrative strategies for targeting the androgen receptor addiction of prostate cancer.

P2860

Q24618782-163CADEC-B5FC-40EC-87E5-1D9FC125543E Q24628746-258C3EEF-5034-48BA-B764-7D4026A7A535 Q28728011-3D4DFD2B-DF5B-493B-A255-731AA1404862 Q30469563-37A7124A-79FB-4E54-B884-2EB8BA918483 Q30473608-DB8EDDBA-22CD-476F-9B14-79018E5860CB Q30829844-D591B452-4350-425D-B729-7E163BB45B7B Q33989019-C5FA76EB-CDCA-45D8-9A8A-810EFEDC91D9 Q34100976-D1623854-4149-4BB0-A9BC-D1DB56A93CF5 Q34525461-0FD9C236-F437-4221-80BE-EC8072E498BB Q35122894-6F4F74AD-6E56-4F30-B5EC-127EAC57239B Q35669733-80CF6189-5116-4EE3-BCF3-39CF20FC7E5B Q35788500-9DFCA686-95E0-447C-917E-AB1F6DB1BA6D Q35928226-8D341742-0CF2-4B38-A59A-E0427F71ECB5 Q36081682-84FB6640-D47E-4AE1-B063-76C88F9A7532 Q36327138-DE2BA905-21C4-45F2-975A-0038E835F7D7 Q36704325-CADE3469-3EB3-4884-AA6A-A1699D2DBEFD Q36731575-E0097E4A-E584-46E7-ABCD-A53F63AEBACD Q36768399-AA90BCF0-2EC3-4E63-938B-62D96CE7DAD7 Q36821548-253590C2-D077-4ED4-9A7F-C203A0A5D49C Q37084901-D1C6523E-87F3-4450-84EF-0C742A34C733 Q37105704-8E491E1C-FCB4-46D1-95FF-C0C690E5FEA1 Q37478602-D3D7B6FC-64AF-436F-882A-D4BED52A91F5 Q37645138-10E8A812-076C-464C-BFA6-5AF810209554 Q37948081-C3C0763F-8CDA-43EC-A001-5A029B9DCB7E Q38061933-431B0BF2-CF9D-49C6-8E5E-594D95A2B477 Q38681165-3660FCCD-54E4-4401-BE86-9784CB228AD6 Q38709195-44F3F9E6-B5C3-4364-86E1-B3894D63E5B6 Q38870205-212CB290-7556-4123-888D-4F3EF656E10D Q38886743-848CB6AD-BBE3-4E67-84FC-5771424FBB85 Q38907149-A5D3AF71-4F1E-4394-8382-BEDAF0328849 Q39148961-C6D5B9A8-6476-4B74-A8A4-F6A811EA7EB7 Q39418010-40267235-AA3D-4552-85D6-F317BC11EF0B Q42367885-84CACC13-F7C3-4B77-BCCA-7AF20F2F993D Q42844079-B0B94C24-3736-4AA9-9B3D-32653F8B8D7B Q46026307-44A4BF7C-81C5-4AB5-8712-10C14BB80C8F Q48203969-EDD69B62-3000-4C62-A9FC-9EC38EA135A2 Q50455684-E9732E04-D201-4546-965D-E55523D3EDF4

P2860

Adenosine A(3) receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity.

http://www.wikidata.org/entity/Q37399268

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Adenosine A(3) receptor suppre ...... biting NADPH oxidase activity.

@en

type

label

Adenosine A(3) receptor suppre ...... biting NADPH oxidase activity.

@en

prefLabel

Adenosine A(3) receptor suppre ...... biting NADPH oxidase activity.

@en

P1433

Q37399268-523986E5-F128-4D73-8DA0-04E11D16A673

P1476

Q37399268-0782653B-83CD-4D61-8634-BC0F3BAA8050

P2093

Q37399268-28F1ADF0-6352-4370-811A-31EBF61C9842

Q37399268-38BE929C-B903-413F-9802-FD3E88B0CF76

Q37399268-7837A812-6DC3-4279-B615-E1F7F2AD7052

Q37399268-9DA482BB-EF19-4F34-9128-47DA79F0E3A9

P2860

Q37399268-03A1CF26-FD3E-48A8-93D8-C88EABA60EDA

Q37399268-05120089-3D18-4CF8-AB65-35539BCC398B

Q37399268-0E01FF39-9252-4C18-BA3C-3261474C10B9

Q37399268-1AF9FD19-AE83-44D7-AB6C-8B1F2EA39A44

Q37399268-2052A04F-52BC-4CDA-A13E-B000CF2AA9E0

Q37399268-20EEDC67-66C4-4B0E-83FC-3666D58EAC5C

Q37399268-21626DB0-783E-4F0C-B987-1CA0C8F0D724

Q37399268-22533688-6482-4783-9126-3BE8E7873E5A

Q37399268-27C5EA0D-91FD-41A7-8122-153EBFA46486

Q37399268-29854848-3279-4449-B77B-E058FD48E875

P304

Q37399268-F6C74D7A-AA55-4AE7-AEA2-4098BE5744F2

P31

Q37399268-C67AF4D0-FAEE-47A3-BA45-C65D4FE618F4

P356

Q37399268-FE57BF43-B22C-4916-9F75-0E88AF7C85F0

P433

Q37399268-471A91B8-3318-4230-A6FA-E7DCB48BEA6D

P478

Q37399268-A4936F64-9A2E-40D3-BC38-155498B23F95

P577

Q37399268-3DFE06D6-7F5F-46A0-8F8E-A235F0216982

P5875

Q37399268-EE5FD860-E2C7-4B7C-B787-0024F3BF411D

P698

Q37399268-D60E78EC-3926-403F-A427-F66EEC152000

P932

Q37399268-6AD3EE70-7143-425B-9E07-5BE08B4B787F

P356

P1433

P1476

Adenosine A(3) receptor suppre ...... biting NADPH oxidase activity.

@en

P2093

Debashree Mukherjea

http://www.w3.org/2001/XMLSchema#string

Kounosuke Watabe

http://www.w3.org/2001/XMLSchema#string

Sarvesh Jajoo

http://www.w3.org/2001/XMLSchema#string

Vickram Ramkumar

http://www.w3.org/2001/XMLSchema#string

P2860

Ras-related GTPases and the cytoskeleton

Free radicals in the physiological control of cell function

Cancer statistics, 2008

Cell migration: integrating signals from front to back

The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology

Proinvasive activity of BMP-7 through SMAD4/src-independent and ERK/Rac/JNK-dependent signaling pathways in colon cancer cells

Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromoc

Functional modules and expression of mouse p40(phox) and p67(phox), SH3-domain-containing proteins involved in the phagocyte NADPH oxidase complex

Cloning of rat p47phox and comparison with human p47phox

The phosphorylation of the respiratory burst oxidase component p47phox during neutrophil activation. Phosphorylation of sites recognized by protein kinase C and by proline-directed kinases

P304

1132-1145

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1593/NEO.09744

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38060139

http://www.w3.org/2001/XMLSchema#string

P698

19881949

http://www.w3.org/2001/XMLSchema#string

P932

2767215

http://www.w3.org/2001/XMLSchema#string